The best medicine for a stuffy nose depends on how long you need relief. For most adults, a single oral pseudoephedrine dose of 60 mg is the most effective option, shrinking swollen nasal tissue within 30 to 60 minutes and lasting 4 to 6 hours. Topical oxymetazoline spray acts faster, within 5 to 10 minutes, and holds for up to 12 hours, but it cannot be used beyond 3 consecutive days or it triggers rebound congestion. Saline irrigation is the safest first-line step for pregnancy, children, and mild cases. Oral phenylephrine at 10 mg has been judged no better than placebo. This guide maps each option to the nasal cycle, with cutoff numbers.
What "Stuffy Nose" Actually Is: The Mechanism
A blocked nose is not usually a mass of mucus. It is engorged erectile tissue. The nasal cavity is lined by the inferior and middle turbinates, folds of tissue packed with venous sinusoids that fill and drain on command.
When you inhale an allergen, cold virus, or irritant, mast cells release histamine and leukotrienes. These signal the sinusoids to dilate. Blood pools in the turbinates, they swell by several millimeters, and the airway narrows. Because resistance scales with the fourth power of the radius, even a 1 mm reduction in each nasal passage can roughly triple breathing effort.
The mucus is a secondary player. Excess mucus adds weight and drainage, but the physical blockage is vascular. That single fact explains why decongestant drugs target blood vessels rather than mucus, and why antihistamines only work when histamine is the trigger. In plain terms: a stuffy nose is a swollen blood sponge, and the right medicine squeezes it.
There is also a normal nasal cycle. Every 2 to 4 hours, one nostril becomes dominant while the other congests. This is healthy, not a sign of disease, and it means the "worst" nostril often swaps sides during the day.
The Nasal Cycle and a 12-Hour Decongestant Timeline
Relief is not one event. It is a series of phases, and each medicine type enters at a different point. The table below compresses the typical course for an average adult using a topical spray versus an oral tablet.
| Phase | Time After Dose | Topical Oxymetazoline | Oral Pseudoephedrine 60 mg |
|---|---|---|---|
| Onset | 0 to 10 min | Starts in 5 to 10 min | Starts in 30 to 60 min |
| Peak effect | 15 to 60 min | Near-full opening by 15 min | Clear by 60 min |
| Plateau | 1 to 6 hr | Holds for 10 to 12 hr | Holds for 4 to 6 hr |
| Fade | 6 to 12 hr | Gradual return near hour 12 | Return near hour 5 |
| Redose window | — | Max 2 doses per day | Every 4 to 6 hr, max 240 mg/day |
| Rebound risk | 3+ days | Rising rebound after day 3 | Minimal rebound; systemic effects instead |
Note the mismatch: the spray is twice as long-lasting as the tablet but the tablet is safer for repeated use. This is the central trade-off of stuffy nose medicine, and the rest of this article builds on it.
Quantified Comparison of Stuffy Nose Medicines
A 2015 systematic review and meta-analysis by De Sutter and colleagues, covering more than 2,000 patients, found single-dose decongestants reduced nasal airway resistance by roughly 20 to 40 percent versus placebo. That is the benchmark. Here is how each class measures up.
| Medicine | Class | Onset | Duration | Typical Adult Dose | Rebound Risk | Best For |
|---|---|---|---|---|---|---|
| Pseudoephedrine | Oral decongestant | 30-60 min | 4-6 hr | 60 mg every 4-6 hr (max 240 mg/day) | Low | Daytime, lasting relief |
| Oxymetazoline spray | Topical decongestant | 5-10 min | 10-12 hr | 2-3 sprays per nostril, twice daily | High after 3 days | Fast, severe blockage |
| Xylometazoline spray | Topical decongestant | 5-10 min | 8-10 hr | 1 spray per nostril, up to 3x/day | High after 3-7 days | Alternative to oxymetazoline |
| Phenylephrine (oral) | Oral decongestant | 30 min | 4 hr | 10 mg every 4 hr | Low | Largely ineffective; FDA 2023 review |
| Intranasal corticosteroid | Anti-inflammatory | 12-24 hr | Ongoing | 1-2 sprays daily | None | Allergy-driven blockage |
| Saline rinse | Mechanical | Minutes | 1-3 hr | 240 mL per rinse | None | Pregnancy, children, daily use |
| Oral antihistamine | Antihistamine | 1 hr | 12-24 hr | Per label | None | Allergic rhinitis with sneezing |
The phenylephrine line matters. In September 2023, an FDA advisory panel concluded that oral phenylephrine at 10 mg is not effective as a nasal decongestant because it is extensively metabolized before reaching the nose. Roughly 1 percent of the swallowed dose survives to act on nasal vessels. Many "sinus" products still contain it, so read the label.
One unit note: pseudoephedrine dosing caps at 240 mg per day for adults, while topical oxymetazoline caps at 2 doses per day and 3 consecutive days of use. Both thresholds exist to protect different systems, the heart and the nasal mucosa respectively, so they are not comparable limits and should never be swapped.
Edge Cases: Pregnancy, Children, and High Blood Pressure
Pregnancy changes the recommendation. Oral pseudoephedrine in the first trimester has been associated with a small increase in gastroschisis, a birth defect, so labels warn against it. Per the 2017 ACC/AHA hypertension guidelines, oral decongestants can raise blood pressure by 3 to 5 mmHg and should be avoided in uncontrolled hypertension. Saline rinses and intranasal corticosteroids are the preferred options in both cases.
Children need stricter numbers. Oral decongestants are not recommended under age 6, and between ages 6 and 12 the dose is halved. Saline spray is first-line at any age. The 2022 FDA guidance approved oxymetazoline spray for children as young as 6, not younger.
Older adults face a different edge case. Pseudoephedrine can cause urinary retention in men with enlarged prostates and can interact with MAO inhibitors. A 60 mg dose with an MAOI can push blood pressure dangerously high, so this combination is contraindicated.
The Rebound Congestion Misconception
The most damaging myth is that frequent spray use is harmless. It is not. Rhinitis medicamentosa, or rebound congestion, develops when oxymetazoline is used beyond 3 to 7 days. The drug downregulates alpha-adrenergic receptors on nasal vessels, so when it wears off the turbinates swell larger than before.
The effect is dose-dependent. Studies show rebound signs increase measurably after day 5 and become marked after day 7. By day 10 to 14 of continuous use, some users become fully dependent on the spray to breathe at all. Recovery takes 1 to 3 weeks of abstinence, and the taper is miserable.
The other misconception is the opposite error: people assume saline is a placebo. It is not. A 200 mL hypertonic saline rinse reduces nasal symptom scores by roughly 30 percent versus no treatment, mainly by clearing mediators and mildly shrinking tissue through osmosis. It is slower and weaker than drugs, but it has zero rebound risk.
A third myth is that adding an antihistamine to a decongestant doubles the effect. It does not help a purely congested nose unless sneezing and itching are also present. Antihistamines target histamine, not the vascular swell that causes blockage.
What to Actually Do
Start by matching the medicine to the cause and the time window. Then follow these concrete steps.
- For a mild or occasional blockage, begin with a 240 mL saline rinse twice daily for 3 to 5 days.
- For moderate daytime blockage, take oral pseudoephedrine 60 mg every 4 to 6 hours, never exceeding 240 mg in a day.
- For severe nighttime blockage, use oxymetazoline 2 sprays per nostril at bedtime, capped at 2 doses per day and 3 consecutive days total.
- For allergy-driven blockage, use an intranasal corticosteroid daily, allowing 12 to 24 hours before judging effect.
- For pregnancy or controlled hypertension, skip oral decongestants and use saline plus intranasal steroid.
- Rotate away from any single drug after 5 days if symptoms persist, and reassess the cause.
Red-flag signs that mean stopping self-treatment and seeing a clinician:
- Blockage lasting more than 10 to 14 days without improvement.
- One-sided blockage with facial pain or bloody discharge.
- Fever above 101.3 degrees Fahrenheit with severe headache.
- Vision changes, swelling around the eye, or neck stiffness.
- Chest pain, palpitations, or a severe headache after taking a decongestant.
- Use of a spray for more than 7 consecutive days.
Limitations and What Science Cannot Yet Resolve
Decongestant research has real gaps. The De Sutter meta-analysis pooled small trials with inconsistent outcome measures, and most regimens have never been tested beyond 7 days. We know short-term effect sizes, not the long-term behavior of daily users over months.
Individual response varies widely. Some adults get minimal relief from 60 mg pseudoephedrine while others report full opening; genetics of the alpha-adrenergic receptor likely explain part of this, but the evidence is early-stage. We also lack strong pediatric data above age 6 for most oral decongestants.
Finally, combination products obscure the math. A single "cold and sinus" tablet may contain phenylephrine, acetaminophen, and an antihistamine together, making it hard to isolate which ingredient helps. When in doubt, use single-ingredient products so you can judge each one on its own numbers.